Marko Bagaric

Founder at

Berlin Heals Holding AG

43 year

Health Technology

Finance

Profile

Marko Bagaric is the founder of Berlin Heals Holding AG, founded in 2014, and holds the title of Director.
Mr. Bagaric currently holds the position of Director at Berlin Cures Holding AG.
Former positions include Chief Executive Officer at Berlin Cures GmbH and Portfolio Manager at Swiss Invest Partners AG.

Marko Bagaric active positions

Companies	Position	Start
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies	Director/Board Member	-
Berlin Heals Holding AG Berlin Heals Holding AG Medical SpecialtiesHealth Technology Operates as a holding company through its subsidiaries develops implantable medical devices for the cure of heart failure	Founder	01/01/2014

All active positions of Marko Bagaric

Former positions of Marko Bagaric

Companies	Position	End
Berlin Cures GmbH Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies	Chief Executive Officer	-
Swiss Invest Partners AG Swiss Invest Partners AG Investment ManagersFinance Provides investment advice	Portfolio Manager-Equities	-

See the detail of Marko Bagaric's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marko Bagaric's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Swiss Invest Partners AG Swiss Invest Partners AG Investment ManagersFinance Provides investment advice	Finance
Berlin Cures GmbH Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies	Health Technology
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies	Health Technology
Berlin Heals Holding AG Berlin Heals Holding AG Medical SpecialtiesHealth Technology Operates as a holding company through its subsidiaries develops implantable medical devices for the cure of heart failure	Health Technology